As of January 2025, Tianjin Chase Sun Pharmaceutical has a market cap of $1.57B. This makes Tianjin Chase Sun Pharmaceutical the world's 5904th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.61B | -7.78% |
2023 | $1.75B | -25.35% |
2022 | $2.34B | -27.46% |
2021 | $3.22B | 70.96% |
2020 | $1.89B | 30.48% |
2019 | $1.45B | 15.08% |
2018 | $1.26B | -28.40% |
2017 | $1.75B | -21.55% |
2016 | $2.24B | -22.80% |
2015 | $2.90B | 31.33% |
2014 | $2.21B | -3.24% |
2013 | $2.28B | 65.50% |
2012 | $1.38B | 103.16% |
2011 | $677.78M | -16.54% |
2010 | $812.07M | -1.47% |
2009 | $824.19M | - |